| Filed On | Filing |
|---|---|
| 22 Oct 2015 |
Form 3: Gutedel Jacques, President Intercontinental
Holds 14,948 shares of Common Stock |
| 18 Jun 2014 |
Form 3: Perkins Sherrie L, VP, Mktg & NBD
Holds 3,000 shares of Common Stock |
| 16 Sep 2013 |
Form 3: Hoare Rohan, SR VP Strategic Planning
Holds 0 shares of Common Stock |
| 10 Jan 2013 |
Form 3: KenKnight Bruce H, VP, Emerging Therapies
Holds 29,250 shares of Common Stock |
| 20 Dec 2011 |
Form 3: Perkins Sherrie L, VP, Mktg & NBD
Holds 3,000 shares of Common Stock |
| 11 Apr 2011 |
Form 3: Verratti Mark, VP Sales
Holds 2,501 shares of Common Stock |
| 11 Apr 2011 |
Form 3: Alch Darren, VP & Asst Secretary
Holds 1,751 shares of Common Stock |
| 23 Sep 2010 |
Form 3: Tremmel Jon T, Director
Holds 0 shares of Common Stock |
| 20 May 2009 |
Form 3: Olin Bryan D, VP Quality
Holds 0 shares of Common Stock |
| 20 Jan 2009 |
Form 3: Morris Milton Mayo, VP Research & Development
Holds 0 shares of Common Stock |
| 25 Sep 2008 |
Form 3: Laptewicz Joseph E, Director
Holds 0 shares of Common Stock |
| 08 Aug 2007 |
Form 3: Reinstein James A., VP Sales & Mktg-Genl Mgr Intl
Holds 0 shares of Common Stock |
| 10 Jul 2007 |
Form 3: Browne Gregory H, VP, Finance & CFO
Holds 0 shares of Common Stock |
| 24 May 2007 |
Form 3: Moore Daniel Jeffrey, Director
Holds 0 shares of Common Stock |
| 05 Feb 2007 |
Form 3: Rosenthal Arthur L, Director
No securities owned |
| 05 Feb 2007 |
Form 3: Novak Alfred J, Director
No securities owned |
| 05 Feb 2007 |
Form 3: Schwarz Jeffrey E, Director
Holds 300,000 shares of Common Stock |
| 15 Nov 2006 |
Form 3: Morrison Hugh M, Director
Holds 0 shares of Common Stock |
| 20 Aug 2004 |
Form 3: Advanced Neuromodulation Systems Inc, 10% owner
Holds 3,500,000 shares of Common Stock |
| 13 Jan 2004 |
Form 3: Moore Kevin S, Director
Holds 7,000 shares of Common Stock |
Loading...